EBS 14.55 -0.07 / Emergent Biosolutions ratings | Benzinga

Monday, May 21, 2012

Emergent BioSolutions Announces Stock Repurchase Program of up to $35M (EBS, News, Buybacks / Mon, 07:00am)

Wednesday, April 18, 2012

European morning wrap: Rule, Britannia!, sterling king of the heap (EBS, Markets / Wed, 06:51am)

Wednesday, March 28, 2012

European morning wrap: Can't beat a bit of consolidation, is what I say (EBS, Markets / Wed, 06:53am)

Tuesday, March 27, 2012

European morning wrap: Market in consolidative mood this morning (EBS, Markets / Tue, 06:39am)

Thursday, March 08, 2012

European morning wrap: Yipeeeeeee, risk on!!! (EBS, Markets / Thu, 07:34am)

Monday, March 05, 2012

European morning wrap: Helter skelter….NOT. Is it Monday? (EBS, Markets / Mon, 07:29am)

Sunday, January 29, 2012

Weekly Traders Homework: Frustrated Bears (ASIA, AXAS, AZK, BLTI, DEJ, DUSA, EBS, EGHT, END, ENTR, FLML, FSIN, GSS, GST, HI, HWD, IRDM, JAG, KNX, LOCM, Long Ideas, MDCO, NOG, OCZ, ONTY, PZG, UEC, ZOLT, Short Ideas, Topics, Markets, Trading Ideas, General / Sun, 09:15pm)

Tuesday, January 17, 2012

Emergent BioSolutions Subsidiary Announces Contract Modification (EBS, News, Contracts / Tue, 03:16pm)

Monday, January 09, 2012

Financial Breakfast: Morning News Summary for January 9, 2012 (ANF, BMY, Earnings, EBS, INHX, INSP, MR, News, NFLX, SPRD, TRV, Futures, Guidance, Upgrades, Commodities, Downgrades, Forex, Technicals, FDA, M&A, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Tech, Trading Ideas, General / Mon, 08:26am)
Emergent BioSolutions Expects 2012 Revs $280-$300M vs $309M Est (EBS, News, Guidance / Mon, 08:02am)

Wednesday, December 28, 2011

A Peek Into The Market Before The Trading Starts (ABT, APP, CASC, EBS, KBR, News, STRM, Futures, Global, Pre-Market Outlook, Markets / Wed, 08:59am)
Emergent Announces Plans for TRU-016 Program Following Termination of Collaboration with Abbott (ABT, EBS, News, FDA / Wed, 08:00am)
Emergent Initiates Phase 2 Study of TRU-016 in Combination with Bendamustine in Patients with Relapsed Chronic Lymphocytic Leukemia (EBS, News, FDA / Wed, 08:00am)

Wednesday, December 21, 2011

Emergent BioSolutions Announces Fuad El-Hibri to Retire as CEO (EBS, News, Management / Wed, 03:00pm)

Monday, December 12, 2011

European morning wrap: Risk off, innit bro (EBS / Mon, 08:25am)

Thursday, December 01, 2011

Emergent BioSolutions Receives Orphan Drug Designation for Its TRU-016 Protein Therapeutic for the Treatment of Chronic Lymphocytic Leukemia (EBS, News, FDA / Thu, 08:04am)

Tuesday, November 29, 2011

WABCO Marks Another Industry First for Advanced Safety Technology in China as Part of Contract With Yutong, (ACC, EBS, ESC, News, WBC, Contracts, Global / Tue, 08:02am)

Thursday, November 17, 2011

Emergent BioSolutions Initiates Pivotal Clinical Trial Evaluating a Three-Dose BioThrax Regimen for Post-Exposure Prophylaxis (EBS, News, FDA / Thu, 07:53am)

Monday, October 24, 2011

Top 4 NYSE Stocks In The Biotechnology Industry With The Highest ROE (CBM, EBS, MRX, SHP, Trading Ideas / Mon, 04:29am)

Tuesday, October 04, 2011

UPDATE: Wedbush Lowers PT on EBS to $31 (Analyst Color, EBS, Price Target, Analyst Ratings / Tue, 08:39am)
Wedbush Lowers PT on Emergent BioSolutions to $31 (EBS, Price Target, Analyst Ratings / Tue, 06:44am)

Monday, October 03, 2011

Emergent BioSolutions Receives Award to Supply 44.75 Million Doses of BioThrax to U.S. Government over Five Years (EBS, News, Contracts, FDA / Mon, 07:01am)

Tuesday, September 27, 2011

Progress Software Reports Positive Quarter, Poor Guidance (Earnings, EBS, News, PRGS, Guidance, After-Hours Center / Tue, 04:40pm)

Monday, September 05, 2011

European Morning Wrap: FX Market Labours on Labor Day (EBS, Forex / Mon, 06:23am)

Friday, August 26, 2011

Results of Emergent BioSolutions Phase 1a Study on Adjuvanted BioThrax Anthrax Vaccine Published in the Journal Vaccine (EBS, News, FDA / Fri, 06:53am)

Wednesday, August 17, 2011

Emergent Announces Initiation of a Phase 1b/2 Study of TRU-016 in Combination with Rituximab and Bendamustine in Subjects with Relapsed - Indolent Lymphoma (EBS, News, FDA / Wed, 07:02am)

Tuesday, June 28, 2011

Progress Software Roll Over in the After-Hours (ADP, Earnings, EBS, PRGS, After-Hours Center / Tue, 04:53pm)

Thursday, June 09, 2011

Emergent BioSolutions' Investigational Anthrax Vaccine, NuThrax, Granted Fast Track Designation (EBS, News, FDA / Thu, 02:40pm)

Monday, June 06, 2011

A Peek Into The Market Before The Trading Starts (AAPL, AEO, BRNC, CHK, EBS, News, Futures, Global, Pre-Market Outlook, Markets / Mon, 07:30am)
Emergent BioSolutions Acquires Late-Stage Monoclonal Antibody Cancer Therapy from TenX BioPharma (EBS, News, M&A / Mon, 07:04am)

Friday, May 27, 2011

UPDATE: J.P. Morgan Raises PT on Emergent BioSolutions to $35 (Analyst Color, EBS, Price Target, Analyst Ratings / Fri, 08:02am)
JP Morgan Raises PT On Emergent BioSolutions To $35 (EBS, Price Target, Analyst Ratings / Fri, 07:00am)

Thursday, May 26, 2011

Emergent Biosolutions Ticks over 15% Higher on Anticipated Government Agreement (EBS, News, Contracts, Movers / Thu, 01:20pm)

Monday, May 09, 2011

Top Percentage Gainers and Losers as of 12pm 5/09/11 (SCEI, FFHL ROSE, SMI, DTG, HTZ, SYY, CERS, LFT, ZRAN, OXGN, MOBI, GKK, EBS, TSN) (CERS, DTG, EBS, FFHL, GKK, HTZ, LFT, Long Ideas, MOBI, OXGN, ROSE, SCEI, SMI, SYY, TSN, ZRAN, Short Ideas, Small Cap Analysis, Intraday Update, Markets, Movers, Trading Ideas / Mon, 12:06pm)

Thursday, May 05, 2011

Biotech/ Biodefense Sector Trading Alert (AEMD, EBS, PLX, SIGA, Markets, Trading Ideas / Thu, 01:36pm)

Monday, May 02, 2011

U.S. Government Expands BioThrax Procurement Contract to 17.92M Doses from 14.5M Increasing Contract Value by up to $101 Million (EBS) (EBS, News, Contracts / Mon, 04:42pm)